JAGLX

Janus Henderson Global Life Sciences Fund Class T [JAGLX] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

JAGLX Stock Summary

Top 10 Correlated ETFs

JAGLX

Top 10 Correlated Stocks

JAGLX

In the News

JAGLX Financial details

Company Rating
-
Market Cap
5.37B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.05
Dividend %
0.07%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-4.35%
SMA50
-
SMA100
12.82%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
61.61-75.13
52W High
+16.32%
52W Low
+43.02%
RSI
41
Rel Volume
-
Avg Volume
-
Volume
Perf Week
-0.4%
Perf Month
-3.59%
Perf Quarter
12.05%
Perf Half Y
7.41%
-
-
-
-
Beta
0.73
-
-
Volatility
0.49%, 1.98%
Prev Close
0.46%
Price
87.24
Change
0.46%

JAGLX Financial Performance

JAGLX Dividend History

JAGLX Frequently Asked Questions

What is Janus Henderson Global Life Sciences Fund Class T stock symbol ?

Janus Henderson Global Life Sciences Fund Class T is a US stock and trading under the symbol JAGLX

What is Janus Henderson Global Life Sciences Fund Class T stock quote today ?

Janus Henderson Global Life Sciences Fund Class T stock price is $87.24 today.

Is Janus Henderson Global Life Sciences Fund Class T stock public?

Yes, Janus Henderson Global Life Sciences Fund Class T is a publicly traded company.

Something similar

Top by Market Cap
LLY.DE
BRK-A
BRK-B
ABEC.DE
AMZ.DE
Top Correlated ETFs
MOTI
SDG
2806.HK
IUMS.L
XLB
Top Correlated Stocks
FBIOX
HTHT
CCM
AMCR
IPH.PA
Similar Market Cap
2139.HK
CBDRX
600644.SS
200055.SZ
TDHOY

Company Profile

Financial Services Asset Management - Global
  • Market Capitalization 5.37B
  • Headquarters US
  • IPO Date 1998-12-31

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.